3-methyl-3,8-diaza-bicyclo[3.2.1]octane-8-carboxylic acid ethylamide | 59436-70-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 3-methyl-3,8-diaza-bicyclo[3.2.1]octane-8-carboxylic acid ethylamide
• 英文别名: 8-(N-Ethylcarbamyl)-3-methyl-3,8-diazabicyclo[3.2.1]octane；N-ethyl-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carboxamide
• CAS: 59436-70-3
• 化学式: C₁₀H₁₉N₃O
• 分子量: 197.28
• InChiKey: KBTLAUJTNMSRSI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  35.6
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  3-甲基-3,8-二氮杂双环[3.2.1]辛烷二盐酸盐 、 异氰酸乙酯 、 3-甲基-3,8-二氮杂双环[3.2.1]辛烷-8-羧酸乙酯 在 crude desired product 、 alumina 、 氯仿 作用下， 生成 3-methyl-3,8-diaza-bicyclo[3.2.1]octane-8-carboxylic acid ethylamide
  参考文献：
  名称：

  3-Substituted-8-methyl-3,8-diazabicyclo[3.2.1]octanes

  摘要：

  十二种类似二乙基氨基甲酸酯的化合物，是通过将3-和8-甲基-3,8-二氮杂双环[3.2.1]辛烷、2-甲基-2,5-二氮杂双环[2.2.2]辛烷和2-甲基-2,5-二氮杂双环[2.2.1]庚烷与二乙基氨基甲酰氯、乙酰氯、乙酰异氰酸酯和环己烷羰基氯作用制备而成。这些化合物在结构上类似于二乙基氨基甲酸酯，具有在哌嗪环上的两个或一个碳桥。这些化合物可用作抗丝虫药物和支气管扩张剂。

  公开号：

  US03951980A1

文献信息

• Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors
  申请人：Josien Hubert B.

  公开号：US20100093695A1

  公开（公告）日：2010-04-15

  This invention discloses novel gamma secretase inhibitors of the formula: wherein: L is —O—, —N(R 6 )—, —S—, —S(O)—, or —S(O 2 )—; R 1 is selected from the group consisting of aryl and heteroaryl; R 2 is selected from the group consisting of alkyl, —C(O)—Y, —X—C(O)—Y, -alkylene-X—C(O)—Y, -alkylene-C(O)—Y, -alkylene-cycloalkylene-X—C(O)—Y, -alkylene-cycloalkylene-C(O)—Y, -cycloalkylene-alkylene-X—C(O)—Y, -cycloalkylene-alkylene-C(O)—Y, -cycloalkylene-X—C(O)—Y, -cycloalkylene-C(O)—Y, -alkylene-cycloalkylene-alkylene-X—C(O)—Y, -alkylene-cycloalkylene-alkylene-C(O)—Y, aryl, and heteroaryl; R 3 is selected from the group consisting of aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, and alkoxyalkyl; each R 4 and R 5 is independently selected from the group consisting of H and alkyl; and Y is selected from the group consisting of —NR 8 R 9 , —N(R 6 )—(CH 2 ) b —NR 8 R 9 , aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, and arylheterocycloalkyl; or Y is selected from the group consisting of: One or more compounds of formula I, or formulations comprising such compounds, may be useful, e.g. in treating Alzheimer's Disease.
• US3947445A
  申请人：——

  公开号：US3947445A

  公开（公告）日：1976-03-30
• US3951980A
  申请人：——

  公开号：US3951980A

  公开（公告）日：1976-04-20
• US7998958B2
  申请人：——

  公开号：US7998958B2

  公开（公告）日：2011-08-16